Porphyromonas gingivalis bacteremia increases the permeability of the blood-brain barrier via the Mfsd2a/Caveolin-1 mediated transcytosis pathway

Abstract

Bacteremia induced by periodontal infection is an important factor for periodontitis to threaten general health. P. gingivalis DNA/virulence factors have been found in the brain tissues from patients with Alzheimer’s disease (AD). The blood-brain barrier (BBB) is essential for keeping toxic substances from entering brain tissues. However, the effect of P. gingivalis bacteremia on BBB permeability and its underlying mechanism remains unclear. In the present study, rats were injected by tail vein with P. gingivalis three times a week for eight weeks to induce bacteremia. An in vitro BBB model infected with P. gingivalis was also established. We found that the infiltration of Evans blue dye and Albumin protein deposition in the rat brain tissues were increased in the rat brain tissues with P. gingivalis bacteremia and P. gingivalis could pass through the in vitro BBB model. Caveolae were detected after P. gingivalis infection in BMECs both in vivo and in vitro. Caveolin-1 (Cav-1) expression was enhanced after P. gingivalis infection. Downregulation of Cav-1 rescued P. gingivalis-enhanced BMECs permeability. We further found P. gingivalis-gingipain could be colocalized with Cav-1 and the strong hydrogen bonding between Cav-1 and arg-specific-gingipain (RgpA) were detected. Moreover, P. gingivalis significantly inhibited the major facilitator superfamily domain containing 2a (Mfsd2a) expression. Mfsd2a overexpression reversed P. gingivalis-increased BMECs permeability and Cav-1 expression. These results revealed that Mfsd2a/Cav-1 mediated transcytosis is a key pathway governing BBB BMECs permeability induced by P. gingivalis, which may contribute to P. gingivalis/virulence factors entrance and the subsequent neurological impairments.

References

[1.] Eke PI, . Periodontitis in US Adults: National Health and Nutrition Examination Survey 2009–2014. J. Am. Dent. Assoc., 2018, 149: 576-88.e6.

[2.] Jiao J, . The prevalence and severity of periodontal disease in Mainland China: Data from the Fourth National Oral Health Survey (2015–2016). J. Clin. Periodontol., 2021, 48: 168-179.

[3.] Romandini M, . Periodontitis, edentulism, and risk of mortality: a systematic review with meta-analyses. J. Dent. Res., 2021, 100: 37-49.

[4.] Sadrameli M, Bathini P, Alberi L. Linking mechanisms of periodontitis to Alzheimer’s disease. Curr. Opin. Neurol., 2020, 33: 230-238.

[5.] Kaur T, Uppoor A, Naik D. Parkinson’s disease and periodontitis—the missing link? A review. Gerodontology, 2016, 33: 434-438.

[6.] Ryder, M. I. Porphyromonas gingivalis and Alzheimer disease: Recent findings and potential therapies. J. Periodontol. 91 (Suppl. 1), S45–S49 (2020).

[7.] Ryder MI, Xenoudi P. Alzheimer disease and the periodontal patient: new insights, connections, and therapies. Periodontol 2000, 2021, 87: 32-42.

[8.] Poole S, Singhrao SK, Kesavalu L, Curtis MA, Crean S. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue. J. Alzheimers Dis., 2013, 36: 665-677.

[9.] Dominy SS, . Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci. Adv., 2019, 5: eaau3333.

[10.] Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol., 2018, 14: 133-150.

[11.] Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb. Perspect. Biol., 2015, 7: a020412.

[12.] Nation DA, . Blood-brain barrier breakdown bis an early biomarker of human cognitive dysfunction. Nat. Med., 2019, 25: 270-276.

[13.] Ayloo S, Gu C. Transcytosis at the blood-brain barrier. Curr. Opin. Neurobiol., 2019, 57: 32-38.

[14.] Pritchard, A. B. et al. An Investigation into the effects of outer membrane vesicles and lipopolysaccharide of porphyromonas gingivalis on blood-brain barrier integrity, permeability, and disruption of scaffolding proteins in a human in vitro model. J. Alzheimers Dis. https://doi.org/10.3233/JAD-215054 (2022).

[15.] Nonaka S, Kadowaki T, Nakanishi H. Secreted gingipains from Porphyromonas gingivalis increase permeability in human cerebral microvascular endothelial cells through intracellular degradation of tight junction proteins. Neurochem. Int., 2022, 154: 105282.

[16.] Hu X, . Calcitriol decreases live Porphyromonas gingivalis internalized into epithelial cells and monocytes by promoting autophagy. J. Periodontol., 2020, 91: 956-966.

[17.] Niu L, . Vitamin D decreases Porphyromonas gingivalis internalized into macrophages by promoting autophagy. Oral. Dis., 2021, 27: 1775-1788.

[18.] Filippini A, D’Alessio A. Caveolae and lipid rafts in endothelium: valuable organelles for multiple functions. Biomolecules, 2020, 10: 1218.

[19.] Andreone BJ, . Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis. Neuron, 2017, 94: 581-594.e5.

[20.] Busija AR, Patel HH, Insel PA. Caveolins and cavins in the trafficking, maturation, and degradation of caveolae: implications for cell physiology. Am. J. Physiol. Cell Physiol., 2017, 312: C459-C477.

[21.] Tamai R, Asai Y, Ogawa T. Requirement for intercellular adhesion molecule 1 and caveolae in invasion of human oral epithelial cells by Porphyromonas gingivalis. Infect. Immun., 2005, 73: 6290-6298.

[22.] Tang Z, . Effects of Porphyromonas gingivalis and its underlying mechanisms on Alzheimer-like Tau hyperphosphorylation in Sprague-Dawley rats. J. Mol. Neurosci., 2021, 71: 89-100.

[23.] Wang YX, . Porphyromonas gingivalis induces depression via downregulating p75NTR-mediated BDNF maturation in astrocytes. Brain Behav. Immun., 2019, 81: 523-534.

[24.] Qian X, . Periodontitis deteriorates cognitive function and impairs neurons and glia in a mouse model of Alzheimer’s disease. J. Alzheimers Dis., 2021, 79: 1785-1800.

[25.] Parahitiyawa NB, Jin LJ, Leung WK, Yam WC, Samaranayake LP. Microbiology of odontogenic bacteremia: beyond endocarditis. Clin. Microbiol. Rev., 2009, 22: 46-64.

[26.] Yu, J. J., Lei, S., Li, F. L., Chen, S. S. & Tang, X. L. Effects of Porphyromonas gingivalis injected through tail vein on the expressions of biomarkers in neural stem cells and neurons of wild-type rats hippocampus. Zhonghua Kou Qiang Yi Xue Za Zhi 57, 375–383 (2022).

[27.] Xuan Y, . Tanshinone IIA attenuates atherosclerosis in apolipoprotein E knockout mice infected with Porphyromonas gingivalis. Inflammation, 2017, 40: 1631-1642.

[28.] Delbosc S, . Elastase inhibitor AZD9668 treatment prevented progression of experimental abdominal aortic aneurysms. J. Vasc. Surg., 2016, 63: 486-92.e1.

[29.] Tomás I, Diz P, Tobías A, Scully C, Donos N. Periodontal health status and bacteraemia from daily oral activities: systematic review/meta-analysis. J. Clin. Periodontol., 2012, 39: 213-228.

[30.] Guo H, . The effect of periodontitis on dementia and cognitive impairment: a meta-analysis. Int. J. Environ. Res. Public Health, 2021, 18: 6823.

[31.] Ilievski V, . Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice. PLoS One, 2018, 13: e0204941.

[32.] Poole S, . Active invasion of Porphyromonas gingivalis and infection-induced complement activation in ApoE-/- mice brains. J. Alzheimers Dis., 2015, 43: 67-80.

[33.] Borkowski J, Schroten H, Schwerk C. Interactions and signal transduction pathways involved during central nervous system entry by Neisseria meningitidis across the blood-brain barriers. Int. J. Mol. Sci., 2020, 21: 8788.

[34.] Devraj G, . HIF-1α is involved in blood-brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis. Acta Neuropathol., 2020, 40: 183-208.

[35.] Zhao WD, . Caspr1 is a host receptor for meningitis-causing Escherichia coli. Nat. Commun., 2018, 9

[36.] Villaseñor R, Lampe J, Schwaninger M, Collin L. Intracellular transport and regulation of transcytosis across the blood-brain barrier. Cell Mol. Life Sci., 2019, 76: 1081-1092.

[37.] Tamai R, Asai Y, Ogawa T. Requirement for intercellular adhesion molecule 1 and caveolae in invasion of human oral epithelial cells by Porphyromonas gingivalis. Infect. Immun., 2005, 73: 6290-6298.

[38.] Potempa J, Sroka A, Imamura T, Travis J. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Curr. Protein Pept. Sci., 2003, 4: 397-407.

[39.] Filippini A, D’Alessio A. Caveolae and lipid rafts in endothelium: valuable organelles for multiple functions. Biomolecules, 2020, 10: 1218.

[40.] Jia L, . Pathogenesis of important virulence factors of porphyromonas gingivalis via Toll-like receptors. Front. Cell Infect. Microbiol., 2019, 9: 262.

[41.] Ben-Zvi A, . Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature, 2014, 509: 507-511.

[42.] Wang Z, . Wnt signaling activates MFSD2A to suppress vascular endothelial transcytosis and maintain blood-retinal barrier. Sci. Adv., 2020, 6: eaba7457.

[43.] Andreone BJ, . Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis. Neuron, 2017, 94: 581-594.e5.

[44.] Stone NL, England TJ, O’ Sullivan SE. A novel transwell blood brain barrier model using primary human cells. Front. Cell Neurosci., 2019, 13: 230.

[45.] Shi S, . Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier. Nanomedicine, 2019, 21: 102061.

[46.] Xie Y, . Establishment of an in vitro model of brain-blood barrier. J. Peking. Univ. (Health Sci.), 2004, 36: 435-438.

[47.] Yang X, . LL-37-induced autophagy contributed to the elimination of live porphyromonas gingivalis internalized in keratinocytes. Front. Cell Infect. Microbiol., 2020, 10: 561761.

Funding

Scientific Research Funding Project of Education Department of Liaoning Province [grant numbers LJKZ0782] National Natural Science Foundation of China [grant numbers 81670999].